Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Diabetic Gastroparesis

Trial Information

Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Official Title: Daily Tadalafil and Gastric Emptying Time in Diabetic Gastroparesis

Summary

The investigators hypothesize that in adult patients with diabetic gastroparesis with Type 1 diabetes (HbA1c ≤ 10.5%), daily tadalafil use will significantly improve gastric emptying compared to baseline as measured by gastric emptying time.

Phase: Phase 4

Sponsor: Mark Feinglos

Locations (1)

Country State City Zip Facility and Contact
United States North Carolina Durham 27710 Duke University Medical Center
Kathryn J Evans, NP
919-684-3758
kathryn.evans@duke.edu

Mark N Feinglos, MD, CM
Principal Investigator

NCT ID:NCT01326117

Date Last Changed: April 17, 2013